Literature DB >> 9031468

Identification of the NO synthase isoforms expressed in human neutrophil granulocytes, megakaryocytes and platelets.

T Wallerath1, I Gath, W E Aulitzky, J S Pollock, H Kleinert, U Förstermann.   

Abstract

Using Western blot and fluorescent immunocytochemistry, NOS III (or ecNOS) and NOS II (or iNOS), but no NOS I (or ncNOS), were identified in preparations of human platelets. Reverse-transcription polymerase chain reactions (RT-PCR) demonstrated NOS III mRNA, but no NOS II mRNA (which is short-lived) and no NOS I mRNA in platelets. Immunofluorescent staining of human bone marrow smears showed the presence of NOS III, but not NOS I in megakaryocytes. A subpopulation of megakaryocytes also expressed NOS II. In preparations of human neutrophils, immunocytochemistry demonstrated NOS I in all cells, whereas no NOS III was detected. The few NOS II positive cells were characterized as contaminating eosinophils. Similarly, in RT-PCR, transcripts for NOS I and NOS II, but not for NOS III, were identified. Thus, the constitutive NOS isoform in megakaryocytes and platelets is NOS III, whereas neutrophils express NOS I. Some megakaryocytes and eosinophils also express NOS II.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9031468

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  26 in total

1.  Characterization of the effects of isoprostanes on platelet aggregation in human whole blood.

Authors:  J H Cranshaw; T W Evans; J A Mitchell
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation.

Authors:  Guoying Zhang; Binggang Xiang; Anping Dong; Radek C Skoda; Alan Daugherty; Susan S Smyth; Xiaoping Du; Zhenyu Li
Journal:  Blood       Date:  2011-07-29       Impact factor: 22.113

Review 3.  Nitric oxide signalling in cardiovascular health and disease.

Authors:  Charlotte Farah; Lauriane Y M Michel; Jean-Luc Balligand
Journal:  Nat Rev Cardiol       Date:  2018-02-01       Impact factor: 32.419

Review 4.  Nitric oxide insufficiency and atherothrombosis.

Authors:  Barbara Voetsch; Richard C Jin; Joseph Loscalzo
Journal:  Histochem Cell Biol       Date:  2004-08-26       Impact factor: 4.304

5.  Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.

Authors:  Jeff S Isenberg; Martin J Romeo; Christine Yu; Christine K Yu; Khauh Nghiem; Jude Monsale; Margaret E Rick; David A Wink; William A Frazier; David D Roberts
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

Review 6.  Membrane tubulovesicular extensions (cytonemes): secretory and adhesive cellular organelles.

Authors:  Svetlana I Galkina; Natalia V Fedorova; Vladimir I Stadnichuk; Galina F Sud'ina
Journal:  Cell Adh Migr       Date:  2013-01-03       Impact factor: 3.405

7.  Nitric oxide regulates neutrophil migration through microparticle formation.

Authors:  Sarah Nolan; Rachel Dixon; Keith Norman; Paul Hellewell; Victoria Ridger
Journal:  Am J Pathol       Date:  2007-12-13       Impact factor: 4.307

8.  Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus.

Authors:  L R Queen; Y Ji; I Goubareva; A Ferro
Journal:  Diabetologia       Date:  2003-10-23       Impact factor: 10.122

9.  Neuronal nitric oxide synthase contributes to the regulation of hematopoiesis.

Authors:  Peter Krasnov; Tatyana Michurina; Michael A Packer; Yuri Stasiv; Naoki Nakaya; Kateri A Moore; Kenneth E Drazan; Grigori Enikolopov
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

10.  Nitric oxide synthase isoforms play distinct roles during acute peritonitis.

Authors:  Jie Ni; Rachel M McLoughlin; Alexandre Brodovitch; Pierre Moulin; Peter Brouckaert; Barbara Casadei; Olivier Feron; Nicholas Topley; Jean-Luc Balligand; Olivier Devuyst
Journal:  Nephrol Dial Transplant       Date:  2009-08-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.